Home > Compound List > Product Information
Rolitetracycline_Molecular_structure_CAS_751-97-3)
Click picture or here to close

Rolitetracycline

Catalog No. DB01301 Name DrugBank
CAS Number 751-97-3 Website http://www.ualberta.ca/
M. F. C27H33N3O8 Telephone (780) 492-3111
M. W. 527.56622 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1152

SYNONYMS

IUPAC name
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(pyrrolidin-1-ylmethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
IUPAC Traditional name
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide

DATABASE IDS

PubChem SID 46507805
PubChem CID 5282179
CAS Number 751-97-3

PROPERTIES

Solubility 555 mg/mL [MERCK INDEX (1996)]

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A pyrrolidinylmethyl tetracycline. [PubChem]
Indication Rolitetracycline is a broad-spectrum antibiotic used in cases needing high concentrations or when oral administration is impractical.
Toxicity Symptoms of overdose include anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region, skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg (I.P. in rat).
External Links
Wikipedia

REFERENCES